Explore more publications!
Switzerland Tech Review
Submit Press Release

Switzerland Tech Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Tech Review.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 4, 2025

Georgetown’s Hoyalytics Students Deliver Data-Driven Insights in Newsmatics Internship Program
November 4, 2025

Georgetown’s Hoyalytics Students Deliver Data-Driven Insights in Newsmatics Internship Program

Indeterminate EIN Presswire
Bridger Insurance Services Selects Radity to Power Modern Distribution Platform
November 4, 2025

Bridger Insurance Services Selects Radity to Power Modern Distribution Platform

Indeterminate EIN Presswire
Hypershell X Series Receives SGS Premium Performance Mark 
November 4, 2025

Hypershell X Series Receives SGS Premium Performance Mark 

Indeterminate EIN Presswire
SGS Strengthens Sustainability Leadership with Participation at COP30
November 4, 2025

SGS Strengthens Sustainability Leadership with Participation at COP30

Indeterminate EIN Presswire
Chainlink and Validation Cloud Collaborate to Power Institutional DeFi With Cross-Chain Interoperability and AI
November 4, 2025

Chainlink and Validation Cloud Collaborate to Power Institutional DeFi With Cross-Chain Interoperability and AI

Indeterminate GlobeNewswire
Fulcrum Launches Fully Insured Crypto Lending Platform Offering Up to 12% APR on BTC, 13% on SOL and 14% on USDT
November 4, 2025

Fulcrum Launches Fully Insured Crypto Lending Platform Offering Up to 12% APR on BTC, 13% on SOL and 14% on USDT

Indeterminate GlobeNewswire
AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
November 4, 2025

AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire
Fünfjahresdaten zu AGAMREE® (Vamorolon) bei Patienten mit DMD zeigen ein verbessertes Sicherheitsprofil bei vergleichbarer Wirksamkeit wie bei der Standardbehandlung mit Kortikosteroiden
November 4, 2025

Fünfjahresdaten zu AGAMREE® (Vamorolon) bei Patienten mit DMD zeigen ein verbessertes Sicherheitsprofil bei vergleichbarer Wirksamkeit wie bei der Standardbehandlung mit Kortikosteroiden

Indeterminate GlobeNewswire
Five-year data of AGAMREE® (vamorolone) in patients with DMD show improved safety profile with comparable effectiveness to standard of care corticosteroids
November 4, 2025

Five-year data of AGAMREE® (vamorolone) in patients with DMD show improved safety profile with comparable effectiveness to standard of care corticosteroids

Indeterminate GlobeNewswire
Starke Verkaufszahlen für Cresemba® (Isavuconazol) in Europa lösen USD 30 Mio. Meilensteinzahlung an Basilea aus
November 4, 2025

Starke Verkaufszahlen für Cresemba® (Isavuconazol) in Europa lösen USD 30 Mio. Meilensteinzahlung an Basilea aus

Indeterminate GlobeNewswire
Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea
November 4, 2025

Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea

Indeterminate GlobeNewswire
Fünfjahresdaten zu AGAMREE® (Vamorolon) bei Patienten mit DMD zeigen ein verbessertes Sicherheitsprofil bei vergleichbarer Wirksamkeit wie bei der Standardbehandlung mit Kortikosteroiden
November 4, 2025

Fünfjahresdaten zu AGAMREE® (Vamorolon) bei Patienten mit DMD zeigen ein verbessertes Sicherheitsprofil bei vergleichbarer Wirksamkeit wie bei der Standardbehandlung mit Kortikosteroiden

Indeterminate GlobeNewswire
Five-year data of AGAMREE® (vamorolone) in patients with DMD show improved safety profile with comparable effectiveness to standard of care corticosteroids
November 4, 2025

Five-year data of AGAMREE® (vamorolone) in patients with DMD show improved safety profile with comparable effectiveness to standard of care corticosteroids

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions